While targets such as AKT1, IL-1β, and IL-6 are well-established in AD pathology, the novelty of our findings lies in demonstrating coordinated modulation of these interconnected pathways simultaneously across both neuronal and intestinal compartments. Here, AKT1 is linked to Alzheimer disease.